Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Menière's disease: combined pharmacotherapy with betahistine and the MAO-B inhibitor selegiline-an observational study.

Strupp M, Kraus L, Schautzer F, Rujescu D.

J Neurol. 2018 Oct;265(Suppl 1):80-85. doi: 10.1007/s00415-018-8809-8. Epub 2018 Mar 12.

PMID:
29532287
2.

Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients.

Hegen H, Adrianto I, Lessard CJ, Millonig A, Bertolotto A, Comabella M, Giovannoni G, Guger M, Hoelzl M, Khalil M, Fazekas F, Killestein J, Lindberg RL, Malucchi S, Mehling M, Montalban X, Rudzki D, Schautzer F, Sellebjerg F, Sorensen PS, Deisenhammer F, Steinman L, Axtell RC.

Neurol Neuroimmunol Neuroinflamm. 2016 Jan 27;3(2):e202. doi: 10.1212/NXI.0000000000000202. eCollection 2016 Apr.

3.

High-dose intravenous interferon-beta in multiple sclerosis patients with high-titer neutralizing antibodies (HINABS II) - A pilot study.

Hegen H, Guger M, Harrer A, Hoelzl M, Kraus J, Skrobal A, Schautzer F, Schmidegg S, Schocke M, Deisenhammer F.

Mult Scler Relat Disord. 2014 Mar;3(2):220-6. doi: 10.1016/j.msard.2013.09.001. Epub 2013 Sep 26.

4.

Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development.

Hegen H, Millonig A, Bertolotto A, Comabella M, Giovanonni G, Guger M, Hoelzl M, Khalil M, Killestein J, Lindberg R, Malucchi S, Mehling M, Montalban X, Polman CH, Rudzki D, Schautzer F, Sellebjerg F, Sørensen PS, Deisenhammer F.

Mult Scler. 2014 Apr;20(5):577-87. doi: 10.1177/1352458513503597. Epub 2013 Sep 5.

PMID:
24009164
5.

Influence of interferon-beta therapy switching on neutralizing antibody titres: results from the Austrian Switch Study.

Gneiss C, Koudouovoh-Tripp PM, Ropele S, Gotwald T, Ehling R, Lutterotti A, Aichner F, Ladurner G, Eggers C, Schautzer F, Künz B, Millonig A, Aspeck E, Reindl M, Berger T, Fazekas F, Deisenhammer F.

Mult Scler. 2009 Dec;15(12):1481-8. doi: 10.1177/1352458509347153. Epub 2009 Nov 13.

PMID:
19965519
6.

Smoking is a risk factor for early conversion to clinically definite multiple sclerosis.

Di Pauli F, Reindl M, Ehling R, Schautzer F, Gneiss C, Lutterotti A, O'Reilly E, Munger K, Deisenhammer F, Ascherio A, Berger T.

Mult Scler. 2008 Sep;14(8):1026-30. doi: 10.1177/1352458508093679. Epub 2008 Jul 16.

PMID:
18632775
7.

Vestibular loss causes hippocampal atrophy and impaired spatial memory in humans.

Brandt T, Schautzer F, Hamilton DA, Brüning R, Markowitsch HJ, Kalla R, Darlington C, Smith P, Strupp M.

Brain. 2005 Nov;128(Pt 11):2732-41. Epub 2005 Sep 1.

PMID:
16141283
8.

4-aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain.

Kalla R, Glasauer S, Schautzer F, Lehnen N, Büttner U, Strupp M, Brandt T.

Neurology. 2004 Apr 13;62(7):1228-9. No abstract available.

PMID:
15079036
9.

Spatial memory deficits in patients with chronic bilateral vestibular failure.

Schautzer F, Hamilton D, Kalla R, Strupp M, Brandt T.

Ann N Y Acad Sci. 2003 Oct;1004:316-24.

PMID:
14662471
10.

Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.

Strupp M, Schüler O, Krafczyk S, Jahn K, Schautzer F, Büttner U, Brandt T.

Neurology. 2003 Jul 22;61(2):165-70.

PMID:
12874393
11.

Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event.

Berger T, Rubner P, Schautzer F, Egg R, Ulmer H, Mayringer I, Dilitz E, Deisenhammer F, Reindl M.

N Engl J Med. 2003 Jul 10;349(2):139-45.

12.

A novel and rapid assay for the detection of neutralizing antibodies against interferon-beta.

Kob M, Harvey J, Schautzer F, Kascha S, Bibl D, Egg R, Reindl M, Berger T, Deisenhammer F.

Mult Scler. 2003 Feb;9(1):32-5.

PMID:
12617265
13.

[Integration of drug therapy and psychotherapy concepts in treatment of depression].

Scholz H, Schautzer F.

Wien Med Wochenschr. 1998;148(15-16):364-9. Review. German.

PMID:
9857437
14.

Video rating analysis of effect of maprotiline in patients with dementia and depression.

Fuchs A, Hehnke U, Erhart C, Schell C, Pramshohler B, Danninger B, Schautzer F.

Pharmacopsychiatry. 1993 Mar;26(2):37-41.

PMID:
8378411

Supplemental Content

Loading ...
Support Center